Arrowhead Pharmaceuticals Inc. News, Arrowhead Pharmaceuticals Inc. Quote, ARWR Quote

Arrowhead Pharmaceuticals Inc. (NQ:ARWR) Delayed: 74.52 +2.87 (4.01%)

Prev. Close

$71.65

Today 6M 1Y 5Y

Open

$72.81

52 Wk High

$8.22

52 Wk Low

$3.07

Day High

$74.70

Day Low

$72.62

P/E

N/A

EPS

$-1.30

Volume

1,612,497

Friends, Peers and Foes (?): SRPT, ABBV, SUPN, ARGX, BBIO (more...)

ALERTS | RSS

Jul 21, 2026 07:30 AM Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Third Quarter Results
Jul 13, 2026 04:07 PM Stifel Starts Arrowhead Pharma (ARWR) at Buy
Jul 2, 2026 06:43 AM H.C. Wainwright Reiterates Buy Rating on Arrowhead Pharma (ARWR)
Jun 22, 2026 12:36 PM EU approves Arrowhead's plozasiran for rare triglyceride disorder
Jun 22, 2026 12:33 PM Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
Jun 18, 2026 07:30 AM Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
Jun 17, 2026 09:44 PM Form 4 ARROWHEAD PHARMACEUTICAL For: Jun 15 Filed by: Cohen Matthew Gregory
Jun 17, 2026 09:44 PM Form 3 ARROWHEAD PHARMACEUTICAL For: Jun 15 Filed by: Cohen Matthew Gregory
Jun 16, 2026 04:07 PM Arrowhead Pharmaceuticals appoints Dr. Matt Cohen to its board of directors
Jun 16, 2026 04:03 PM Form 8-K ARROWHEAD PHARMACEUTICAL For: Jun 12

Entities mentioned with ARWR

View All Entities